First Time Loading...

Kinnate Biopharma Inc
NASDAQ:KNTE

Watchlist Manager
Kinnate Biopharma Inc Logo
Kinnate Biopharma Inc
NASDAQ:KNTE
Watchlist
Price: 2.65 USD Market Closed
Updated: Apr 24, 2024
Section:
 

Wall Street
Price Targets

KNTE Price Targets Summary
Kinnate Biopharma Inc

Wall Street analysts forecast KNTE stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KNTE is 2.41 USD with a low forecast of 2.02 USD and a high forecast of 2.72 USD.

KNTE Lowest Forecast
Wall Street Target
2.02 USD
24% Downside
KNTE Average Forecast
Wall Street Target
2.41 USD
9% Downside
KNTE Highest Forecast
Wall Street Target
2.72 USD
3% Upside
Lowest
Price Target
2.02 USD
24% Downside
Average
Price Target
2.41 USD
9% Downside
Highest
Price Target
2.72 USD
3% Upside
Kinnate Biopharma Inc Competitors:
Price Targets
ARGX
argenx SE
36% Upside
INCY
Incyte Corp
49% Upside
TGTX
TG Therapeutics Inc
118% Upside
4587
PeptiDream Inc
68% Upside
ARGX
argenx SE
36% Upside
INCY
Incyte Corp
49% Upside
TGTX
TG Therapeutics Inc
118% Upside
4587
PeptiDream Inc
68% Upside
P
214450
PharmaResearch Co Ltd
51% Upside
OVID
Ovid Therapeutics Inc
134% Upside
IGMS
IGM Biosciences Inc
181% Upside
HALO
Halozyme Therapeutics Inc
34% Upside

Revenue
Forecast

Revenue Estimate
Kinnate Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Kinnate Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Kinnate Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

See Also

Summary
KNTE intrinsic value, competitors valuation, and company profile.
DCF Valuation
KNTE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KNTE stock valuation using valuation multiples.
Wall Street Estimates
KNTE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KNTE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KNTE's stock price target?
Price Target
2.41 USD

According to Wall Street analysts, the average 1-year price target for KNTE is 2.41 USD with a low forecast of 2.02 USD and a high forecast of 2.72 USD.

ALPHA SPREAD
Join more than 130,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.